Kura Oncology, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -9.44 | -100% |
| P/S |
|
0 | 33.77 | -100% |
|
|
| P/BV |
|
2.52 | 4.83 | -47.73% |
|
|
| P/FCF |
|
-6.25 | 61 | -110.24% |
|
|
| Ev/Ebitda |
|
-5.96 | -22.17 | -73.14% |
|
|
| Ev/S |
|
0 | 22.57 | -100% |
|
|
| Ev/FCF |
|
-7.86 | 68.76 | -111.43% |
|
|
| E/P |
|
-0.1954 | 0.0178 | -1199.38% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | 0 | 0% |
| ROE |
|
-38.42 | 9.61 | -499.72% |
|
|
| ROA |
|
-34 | 0.3443 | -9975.83% |
|
|
| ROIC |
|
-24.6 | 7.63 | -422.23% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-41.74 | 15.45 | -370.14% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0657 | -3.68 | -98.21% | -0.0779 | -15.68% |
| Nеt Debt/Ebitda |
|
0.122 | -3.44 | -103.55% |
|
|
| Debt/Ratio |
|
0.0241 | 0.1986 | -87.84% |
|
|
| Debt/Equity |
|
4.34 | 1.66 | 160.79% |
|
|
| Debt/Net Income |
|
-0.071 | 10.32 | -100.69% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -57.64 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
163.67 | -90.94 | -279.98% | ||
| Growth impulse Net Income in 5 years |
|
142.27 | -97.8 | -245.47% | ||
| Growth impulse FCF in 5 years |
|
127.26 | -108.72 | -217.05% | ||
| Growth impulse EPS in 5 years |
|
38.03 | -142.05 | -126.77% |
IP Score
3.68/10
